Skip to content

Clinical trials

Dementia trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Country / region: Puerto Rico Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20122
20141
20151
20171
20203
20211
20221
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Active, not recruiting4
Completed4
Terminated3
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Washington University School of Medicine6
AstraZeneca2
Bristol-Myers Squibb2
Eli Lilly and Company2
Duke University1
IGC Pharma, LLC1
Novartis1
Novartis Pharmaceuticals1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Prilenia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia18
Alzheimer Disease16
Cognitive Dysfunction4
Brain Diseases3
Central Nervous System Diseases3
Mental Disorders3
Nervous System Diseases3
Neurocognitive Disorders3
Neurodegenerative Diseases2
Plaque, Amyloid2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.